A 3D printer that enables tablet manufacturing using innovative 3D printing technology, revolutionizing personalized medicine.
FabRx, a UK company specializing in pharmaceuticals and biotechnology that spun out from University College London, has launched a 3D printer aimed at the manufacturing of solid dosage forms focused on personalized medicine. The Printlet, a tablet manufactured using a 3D printer with three different nozzles (for powder, gel, and filament), has been tested in various research institutions, hospitals, and pharmacies overseas, and is now available for sale domestically. By using registered formulations and manufacturing conditions in dedicated software, it can be applied in medical settings for personalized medicine, as well as in drug discovery and clinical trial drug manufacturing.
Inquire About This Product
Related Videos
basic information
The M3DIMAKER, a 3D printer developed by FabRx, is a groundbreaking printer that allows the use of three different nozzles. It is managed by dedicated software, enabling the adjustment of prescribed formulations at clinical trial sites by selecting pre-registered prescriptions, thus allowing the creation of tablets. It features fingerprint authentication to restrict operational permissions, allowing only authorized individuals to operate it. Additionally, it has a monitoring camera for error checking to detect any issues that may arise during manufacturing. It can be used not only for the production of formulations tailored to individual medical needs but also for drug discovery research, formulation development, and clinical research applications.
Price information
Please contact us.
Price range
P7
Delivery Time
Applications/Examples of results
3D printer specialized in personalized medicine. Research equipment suitable for drug discovery research, formulation development, and clinical research applications.
Detailed information
-
Ｍ３ＤＩＭＡＫＥＲ
catalog（1）
Download All Catalogs
News about this product（4）
Company information
Starting as an import trading company in 1927, we have been developing our business with many overseas suppliers and domestic customers over the years. Through our services of connecting the two together, Higuchi has become the well trusted "Japan distribution channel" for suppliers, and the "dependable vendor" who provides a stable supply of the latest high-valued overseas products to customers. Today, we conduct not only importing but also exporting businesses, trilateral trades, and overseas business investments as well. We have also expanded to local subsidiaries in the United States and China, to which we are able to effectively network overseas. Higuchi believes in the criticalness of providing a stable supply to customers, and we also place the highest priority on the coexistence with suppliers, to whom we can mutually develop together in a long-term perspective. Your support and consideration to our corporate philosophy would be much appreciated.
